<?xml version="1.0" encoding="utf-8" ?>
<pageContent>
    <id><![CDATA[OTS_SA_R4_D040]]></id>
	<title><![CDATA[<Introtext style="font-family:Helvetica; font-size:14pt; font-weight:bold; color:#cc0033; margin:10px -5px 10px 5px; width:738px; padding:5px 0 5px 5px; background:#e8e8e8; border-bottom:1px solid #333; display:block;">Pressure from your District Manager</Introtext>]]></title>
	<title2><![CDATA[]]></title2>
	<instructions><![CDATA[<welcomeText style=" font-family:Helvetica; font-size:11pt; line-height:18pt; text-align:justify; font-weight:bold; color:#333; display:block; margin:0 10px 10px">However, Dr. Hayes left the meeting prior to making a prescribing decision.  It’s the end of the quarter, and you are below 100% to goal. Your district manager is expressing concern regarding your sales results.<BR><BR>What is the right action to take at this time?</welcomeText >]]></instructions>
	<choices>
		<choice>
			<id><![CDATA[1]]></id>
			<isCorrect><![CDATA[YES]]></isCorrect>
			<choiceText><![CDATA[<welcomeText style=" font-family:Helvetica; font-size:12pt; line-height:18pt; text-align:justify; font-weight:normal; color:#333; display:block; margin:0 10px 10px"><b>A</b>. Spend the time necessary to identify any concerns Dr. Hayes and Dr. Bennett may have about the risks and fair balance of using your product for bipolar I disorder. This is a necessary step to ensure that there are no problems later.</welcomeText>]]></choiceText>
			<KPIs totalScore="30">
				<KPI marks="10"><![CDATA[Customer Results Score]]></KPI>
				<KPI marks="10"><![CDATA[Sales Progress Score]]></KPI>
				<KPI marks="10"><![CDATA[Trusted Advisor Relationship Score]]></KPI>
			</KPIs>
			<branchTo><![CDATA[OTS_SA_R4_D040_A010]]></branchTo>
		</choice>
		<choice>
			<id><![CDATA[2]]></id>
			<isCorrect><![CDATA[NO]]></isCorrect>
			<choiceText><![CDATA[<welcomeText style=" font-family:Helvetica; font-size:12pt; line-height:18pt; text-align:justify; font-weight:normal; color:#333; display:block; margin:0 10px 10px"><b>B</b>. It’s time to close the sale. Stop by Sunnydale Psychiatry again and meet with Dr. Hayes, reinforcing the benefits of using your product for bipolar I disorder.</welcomeText>]]></choiceText>
			<KPIs totalScore="5">
				<KPI marks="5"><![CDATA[Customer Results Score]]></KPI>
				<KPI marks="5"><![CDATA[Sales Progress Score]]></KPI>
				<KPI marks="-5"><![CDATA[Trusted Advisor Relationship Score]]></KPI>
			</KPIs>
			<branchTo><![CDATA[OTS_SA_R4_D040_B010]]></branchTo>
		</choice>
		<choice>
			<id><![CDATA[3]]></id>
			<isCorrect><![CDATA[NO]]></isCorrect>
			<choiceText><![CDATA[<welcomeText style=" font-family:Helvetica; font-size:12pt; line-height:18pt; text-align:justify; font-weight:normal; color:#333; display:block; margin:0 10px 10px"><b>C</b>. It doesn’t have to take a long time to move through the prescribing cycle. Immediately provide Dr. Hayes the information on product coverage and patient cost, and any other information he may need to move forward with prescribing.</span></welcomeText>]]></choiceText>
			<KPIs totalScore="5">
				<KPI marks="0"><![CDATA[Customer Results Score]]></KPI>
				<KPI marks="5"><![CDATA[Sales Progress Score]]></KPI>
				<KPI marks="0"><![CDATA[Trusted Advisor Relationship Score]]></KPI>
			</KPIs>
			<branchTo><![CDATA[OTS_SA_R4_D040_B010]]></branchTo>
		</choice>
		<choice>
			<id><![CDATA[4]]></id>
			<isCorrect><![CDATA[NO]]></isCorrect>
			<choiceText><![CDATA[<welcomeText style=" font-family:Helvetica; font-size:12pt; line-height:18pt; text-align:justify; font-weight:normal; color:#333; display:block; margin:0 10px 10px"><b>D</b>. Do more than just provide the product coverage and patient cost information.  Remind Dr. Hayes and Dr. Bennett of the value that you personally and your product have already brought to Sunnydale Psychiatry’s priorities.</welcomeText>]]></choiceText>
			<KPIs totalScore="10">
				<KPI marks="5"><![CDATA[Customer Results Score]]></KPI>
				<KPI marks="5"><![CDATA[Sales Progress Score]]></KPI>
				<KPI marks="0"><![CDATA[Trusted Advisor Relationship Score]]></KPI>
			</KPIs>
			<branchTo><![CDATA[OTS_SA_R4_D040_C010]]></branchTo>
		</choice>
		<!--<feedbackText><![CDATA[]]></feedbackText>-->
	</choices>
 <summary><![CDATA[<welcomeText style=" font-family:Helvetica; font-size:12pt; line-height:18pt; text-align:justify; font-weight:normal; color:#333; display:block; margin:0 10px 10px">Although you may be getting pressure from your district manager, or maybe even the physician, to close the sale, making sure you have addressed concerns about the possible risks and fair balance for the new indication increases the chances that the sale will be successful (Choice A). This doesn’t have to take a long time, and you might even expand prescribing more than what the customer originally intended. Moving forward with patient cost and insurance coverage too early without giving the customer the opportunity to express any concerns about risks (Choices B and C) may prove successful in the short term, but it could slow things down later. If the customer has to identify risks on their own without your guidance, you risk damaging your position as a trusted advisor. Choice D focuses too heavily on your past relationship with the customer and your product’s value, rather than on the customer’s needs. Choice A is the best choice.</welcomeText>]]></summary>
</pageContent>